RMD Reported Revenue of $1.41 Billion for the Quarter
TL;DR: ResMed posted revenue of $1.41 billion for the quarter ended September 30, 2026, with Net Income of $418 million and diluted earnings of $2.92 per share.
XNYS · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: ResMed posted revenue of $1.41 billion for the quarter ended September 30, 2026, with Net Income of $418 million and diluted earnings of $2.92 per share.
ResMed (RMD) had 1 Form 144 pre-sale notice filed on 2026-07-07. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
ResMed (RMD) had 1 Form 144 pre-sale notice filed on 2026-06-08. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At least one filing…
ResMed (RMD) had 1 Form 144 pre-sale notice filed on 2026-05-27. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction.
TL;DR: ResMed posted Q3 fiscal 2026 revenue of $1.43B, up 10.8% from $1.29B in the year-ago quarter, with GAAP gross margin expanding 290 basis points to 62.2%.
open-market Form 4 only - grants, exercises, tax withholding excluded
0 buyers - 3 unique sellers · 7 accumulating - 4 trimming - 2 unchanged
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| November 11, 2026 | Rider Michael J | Global General Counsel | TAX_WITHHOLD | -172.99 | $234 | ~$40K |
| November 11, 2026 | Rider Michael J | Global General Counsel | TAX_WITHHOLD | -724.41 | $234 | ~$0.2M |
| November 11, 2026 | Rider Michael J | Global General Counsel | TAX_WITHHOLD | -498.62 | $234 | ~$0.1M |
| November 11, 2026 | Rider Michael J | Global General Counsel | TAX_WITHHOLD | -547.47 | $234 | ~$0.1M |
| November 11, 2026 | Gill Harjit | — | TAX_WITHHOLD | -35.73 | $234 | ~$8K |
| November 11, 2026 | De Witte Jan | — | TAX_WITHHOLD | -59.98 | $234 | ~$14K |
| November 11, 2026 | Farrell Peter C | — | TAX_WITHHOLD | -169.14 | $234 | ~$40K |
| November 11, 2026 | Bloomer Aaron | Chief Financial Officer | TAX_WITHHOLD | -1,095.14 | $234 | ~$0.3M |
| November 11, 2026 | Farrell Michael J. | Chairman and CEO | TAX_WITHHOLD | -2,435.84 | $234 | ~$0.6M |
| November 11, 2026 | Farrell Michael J. | Chairman and CEO | TAX_WITHHOLD | -2,209.79 | $234 | ~$0.5M |
| November 11, 2026 | Farrell Michael J. | Chairman and CEO | TAX_WITHHOLD | -3,465.75 | $234 | ~$0.8M |
| November 9, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | -4,310 | — | — |
| November 9, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | -683 | — | — |
| November 9, 2026 | Farrell Michael J. | Chairman and CEO | SELL | -4,993 | $235 | ~$1.2M |
| November 9, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | 4,310 | $146 | ~$0.6M |
| November 9, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | 683 | $146 | ~$100K |
| October 23, 2026 | Rider Michael J | Global General Counsel | SELL | -400 | $255 | ~$0.1M |
| October 7, 2026 | Farrell Michael J. | Chairman and CEO | SELL | -4,991 | $226 | ~$1.1M |
| October 7, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | 4,991 | $146 | ~$0.7M |
| October 7, 2026 | Farrell Michael J. | Chairman and CEO | OPTION_EXERCISE | -4,991 | — | — |
| Date | Filer | Relationship | Est. shares | Filing |
|---|---|---|---|---|
| November 9, 2026 | Farrell Michael J. | — | 4,993 | SEC |
| October 23, 2026 | Rider Michael J | — | 400 | SEC |
| October 7, 2026 | Farrell Michael J. | — | 4,991 | SEC |
| September 8, 2026 | Farrell Michael J. | — | 4,991 | SEC |
| September 2, 2026 | Peter C Farrell | — | — | SEC |
| August 7, 2026 | Farrell Michael J. | — | 4,991 | SEC |
| August 5, 2026 | Peter C Farrell | — | — | SEC |
| July 7, 2026 | Farrell Michael J. | — | 4,991 | SEC |
| June 8, 2026 | Farrell Michael J. | — | 4,991 | SEC |
| May 27, 2026 | Sandercock Brett | — | 8,000 | SEC |
| Date | Insider | Title | Relationship | Shares | Filing |
|---|---|---|---|---|---|
| May 4, 2026 | — | — | — | — | SEC |
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| Vanguard Group | 18,882,403 | ~$4.5B | prior history unverified | January 29, 2026 |
| BlackRock | 12,348,652 | ~$3.0B | prior history unverified | February 12, 2026 |
| BlackRock | 12,094,023 | ~$2.7B | -2.1% | May 13, 2026 |
| BlackRock | 12,317,194 | ~$2.4B | 1.9% | August 7, 2026 |
| BlackRock | 11,691,961 | ~$2.2B | prior history unverified | August 13, 2024 |
| State Street | 6,625,408 | ~$1.6B | prior history unverified | February 13, 2026 |
| State Street | 6,643,168 | ~$1.5B | 0.3% | May 15, 2026 |
| State Street | 6,680,735 | ~$1.3B | 0.6% | August 7, 2026 |
| Morgan Stanley | 2,891,697 | ~$696.5M | prior history unverified | May 27, 2026 |
| Morgan Stanley | 2,686,821 | ~$603.1M | -7.1% | May 15, 2026 |
| Morgan Stanley | 1,928,931 | ~$375.9M | -28.2% | August 13, 2026 |
| Goldman Sachs | 979,419 | ~$235.9M | prior history unverified | March 25, 2026 |
| Goldman Sachs | 1,160,426 | ~$226.1M | 15.6% | August 14, 2026 |
| Goldman Sachs | 1,004,205 | ~$225.4M | 2.5% | May 15, 2026 |
| AQR Capital | 910,623 | ~$177.1M | 160.3% | August 14, 2026 |
| JP Morgan Chase | 847,736 | ~$168.2M | 17.9% | August 12, 2026 |
| JP Morgan Chase | 719,347 | ~$158.3M | 18.8% | May 13, 2026 |
| JP Morgan Chase | 605,408 | ~$145.8M | prior history unverified | February 11, 2026 |
| Citadel Advisors | 610,484 | ~$119.0M | 45.3% | August 14, 2026 |
| Fidelity (FMR) | 415,813 | ~$100.2M | prior history unverified | February 17, 2026 |